MyoSense- Automated Muscle Hypertonicity Classification System
NCT ID: NCT02076581
Last Updated: 2015-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
53 participants
OBSERVATIONAL
2014-02-28
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wearable Sensors to Detect Atypical Muscle Activation in Young Infants
NCT06970522
Investigating New Methods to Study Movement in Children and Young Adults With Movement Disorders.
NCT06498596
Use of EMG to Assess Clinical Hypertonia
NCT00472914
Validation of an Obstacle Course Used in Patients With Muscle Tightness
NCT00776048
Quantification of Upper Extremity Hypertonia
NCT00285870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke
Ten individuals with chronic stroke and limb spasticity will be recruited.
No interventions assigned to this group
Dystonia
Ten individuals with dystonic limbs and no spasticity will be recruited.
No interventions assigned to this group
Cerebral Palsy
Ten individuals with Cerebral palsy with the potential for a mix of dystonic and spastic abnormal tone in their affected limbs will be recruited.
No interventions assigned to this group
Neurologically normal
Thirty individuals without neurological injury that are age matched to the rest of the study population will be recruited.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over the age of five.
Exclusion Criteria
* Limited range of motion in the knee, ankle, wrist or elbow due to orthopedic injury or severe contraction.
* Cognitive impairment resulting in inability to provide informed consent or complete the protocol.
* Under the age of five.
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Great Lakes NeuroTechnologies Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph P Giuffrida, PhD
Role: PRINCIPAL_INVESTIGATOR
Great Lakes NeuroTechnologies Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Great Lakes NeuroTechnologies
Valley View, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NS076052-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.